Creagh F, Teece M, Williams S, Didcote S, Perkins W, Hashim F, Rees Smith B
Clin Endocrinol (Oxf). 1985 Oct;23(4):395-404. doi: 10.1111/j.1365-2265.1985.tb01097.x.
Improved receptor and bioassays have been used to compare TSH receptor binding and thyroid stimulating activities in unextracted sera from 110 patients with Graves' disease. The two parameters showed a significant correlation (r = 0.65; P less than 0.001) although there were some clear discrepancies. Dose-response studies in 17 sera showed that both receptor binding and thyroid stimulating responses always increased with increasing doses of serum. In patients who were in relapse or remission following antithyroid drug treatment, the results of both bio- and receptor assays correlated well with disease activity with only one clear discrepancy which could have been attributable to the coexistence of autoimmune stimulation and destruction of the thyroid.
改良的受体及生物测定法已用于比较110例格雷夫斯病患者未提取血清中的促甲状腺激素(TSH)受体结合及甲状腺刺激活性。尽管存在一些明显差异,但这两个参数显示出显著相关性(r = 0.65;P < 0.001)。对17份血清进行的剂量反应研究表明,随着血清剂量增加,受体结合及甲状腺刺激反应均始终增加。在接受抗甲状腺药物治疗后复发或缓解的患者中,生物测定法和受体测定法的结果均与疾病活动密切相关,仅有一处明显差异,这可能归因于自身免疫性刺激与甲状腺破坏并存。